Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: MAP4

Gene summary for MAP4

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

MAP4

Gene ID

4134

Gene namemicrotubule associated protein 4
Gene AliasMAP4
Cytomap3p21.31
Gene Typeprotein-coding
GO ID

GO:0000226

UniProtAcc

P27816


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
4134MAP4CA_HPV_1HumanCervixCC1.82e-035.82e-020.0264
4134MAP4CCI_2HumanCervixCC5.20e-058.20e-010.5249
4134MAP4CCI_3HumanCervixCC9.96e-111.30e+000.516
4134MAP4HTA11_3410_2000001011HumanColorectumAD8.00e-09-3.33e-010.0155
4134MAP4HTA11_347_2000001011HumanColorectumAD2.18e-054.60e-01-0.1954
4134MAP4HTA11_1391_2000001011HumanColorectumAD1.43e-035.48e-01-0.059
4134MAP4HTA11_99999970781_79442HumanColorectumMSS1.24e-02-3.16e-010.294
4134MAP4A015-C-203HumanColorectumFAP1.43e-28-3.57e-01-0.1294
4134MAP4A015-C-204HumanColorectumFAP6.55e-05-1.79e-01-0.0228
4134MAP4A014-C-040HumanColorectumFAP2.73e-06-5.65e-01-0.1184
4134MAP4A002-C-201HumanColorectumFAP1.04e-14-3.73e-010.0324
4134MAP4A002-C-203HumanColorectumFAP1.95e-03-1.86e-010.2786
4134MAP4A001-C-119HumanColorectumFAP1.77e-07-3.37e-01-0.1557
4134MAP4A001-C-108HumanColorectumFAP4.48e-16-1.28e-01-0.0272
4134MAP4A002-C-205HumanColorectumFAP5.31e-27-4.12e-01-0.1236
4134MAP4A015-C-005HumanColorectumFAP2.03e-03-2.27e-01-0.0336
4134MAP4A015-C-006HumanColorectumFAP5.96e-20-3.09e-01-0.0994
4134MAP4A015-C-106HumanColorectumFAP2.39e-09-1.58e-01-0.0511
4134MAP4A002-C-114HumanColorectumFAP2.71e-19-2.34e-01-0.1561
4134MAP4A015-C-104HumanColorectumFAP3.28e-32-3.96e-01-0.1899
Page: 1 2 3 4 5 6 7 8 9 10 11 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
CervixThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.CC: Cervix cancer
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
N_HPV: HPV-infected normal cervix
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
LungThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AAH: Atypical adenomatous hyperplasia
AIS: Adenocarcinoma in situ
IAC: Invasive lung adenocarcinoma
MIA: Minimally invasive adenocarcinoma
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00071639CervixCCestablishment or maintenance of cell polarity63/2311218/187234.25e-118.76e-0963
GO:00300108CervixCCestablishment of cell polarity42/2311143/187234.30e-082.62e-0642
GO:00310988CervixCCstress-activated protein kinase signaling cascade58/2311247/187238.02e-072.89e-0558
GO:00514038CervixCCstress-activated MAPK cascade55/2311239/187232.96e-068.31e-0555
GO:00346129CervixCCresponse to tumor necrosis factor55/2311253/187231.75e-053.32e-0455
GO:00516567CervixCCestablishment of organelle localization76/2311390/187233.17e-055.21e-0476
GO:00093149CervixCCresponse to radiation86/2311456/187233.50e-055.63e-0486
GO:00106399CervixCCnegative regulation of organelle organization68/2311348/187237.40e-051.03e-0368
GO:19021153CervixCCregulation of organelle assembly40/2311186/187232.92e-043.15e-0340
GO:00094112CervixCCresponse to UV33/2311149/187235.51e-045.29e-0333
GO:00313456CervixCCnegative regulation of cell projection organization39/2311186/187235.86e-045.57e-0339
GO:00072545CervixCCJNK cascade35/2311167/187231.10e-039.09e-0335
GO:01200328CervixCCregulation of plasma membrane bounded cell projection assembly38/2311186/187231.14e-039.35e-0338
GO:00604917CervixCCregulation of cell projection assembly38/2311188/187231.40e-031.10e-0238
GO:00094163CervixCCresponse to light stimulus54/2311320/187231.03e-024.97e-0254
GO:0051656ColorectumADestablishment of organelle localization131/3918390/187233.00e-092.06e-07131
GO:0010639ColorectumADnegative regulation of organelle organization114/3918348/187231.41e-076.49e-06114
GO:0007163ColorectumADestablishment or maintenance of cell polarity77/3918218/187235.72e-072.08e-0577
GO:0030010ColorectumADestablishment of cell polarity50/3918143/187236.90e-051.11e-0350
GO:0007051ColorectumADspindle organization58/3918184/187234.71e-045.20e-0358
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
MAP4SNVMissense_Mutationnovelc.3131A>Gp.Asn1044Serp.N1044SP27816protein_codingdeleterious(0.01)possibly_damaging(0.641)TCGA-AR-A5QQ-01Breastbreast invasive carcinomaFemale>=65III/IVChemotherapycarboplatinPD
MAP4SNVMissense_Mutationc.71A>Gp.Asp24Glyp.D24GP27816protein_codingdeleterious(0)probably_damaging(0.997)TCGA-C8-A26Y-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
MAP4insertionIn_Frame_Insnovelc.3410_3411insCTTACTGTCCAAAACTACAAGGACAGTGACAGTTCTGACAGGp.Gln1137delinsHisLeuLeuSerLysThrThrArgThrValThrValLeuThrGlyp.Q1137delinsHLLSKTTRTVTVLTGP27816protein_codingTCGA-A8-A0A2-01Breastbreast invasive carcinomaFemale>=65I/IIHormone TherapytamoxiphenSD
MAP4insertionNonsense_Mutationnovelc.2692_2693insACTGCATATAGTGATGGAGAAAGATCACAGTp.Pro898HisfsTer4p.P898Hfs*4P27816protein_codingTCGA-BH-A0EE-01Breastbreast invasive carcinomaFemale>=65I/IIChemotherapydocetaxelSD
MAP4SNVMissense_Mutationnovelc.1241N>Tp.Ser414Leup.S414LP27816protein_codingdeleterious(0)possibly_damaging(0.656)TCGA-DS-A5RQ-01Cervixcervical & endocervical cancerFemale>=65I/IIChemotherapycisplatinCR
MAP4SNVMissense_Mutationnovelc.2122N>Gp.Gln708Glup.Q708EP27816protein_codingdeleterious(0.04)benign(0.328)TCGA-EK-A2RJ-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
MAP4SNVMissense_Mutationc.3155G>Ap.Gly1052Glup.G1052EP27816protein_codingdeleterious(0)probably_damaging(0.973)TCGA-EK-A2RK-01Cervixcervical & endocervical cancerFemale>=65I/IIUnknownUnknownSD
MAP4SNVMissense_Mutationc.2968G>Tp.Gly990Trpp.G990WP27816protein_codingdeleterious(0)probably_damaging(0.999)TCGA-MU-A5YI-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownPD
MAP4SNVMissense_Mutationnovelc.2544G>Cp.Lys848Asnp.K848NP27816protein_codingdeleterious(0)probably_damaging(0.928)TCGA-VS-A94X-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinPD
MAP4SNVMissense_Mutationnovelc.478G>Tp.Ala160Serp.A160SP27816protein_codingtolerated(0.13)benign(0.039)TCGA-5M-AATE-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownPD
Page: 1 2 3 4 5 6 7 8 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1